Home › Funds › Vestal Point Capital, LP › RVMD

Vestal Point Capital, LP position in RVMD

REVOLUTION MEDICINES INC · Health Care

Vestal Point Capital, LP reported holding 450,000 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$84.3M, representing 1.97% of its reported portfolio and ranking #18 among its reported holdings. Vestal Point Capital, LP has disclosed RVMD holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)450.00K sh
Reported value held$84.28M
Portfolio Weight1.97%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's RVMD position evolved

Vestal Point Capital, LP first disclosed a stake in RVMD in Q4 2023 at 725,000 shares (US$20.8M). The position peaked in Q1 2026 at 2,375,000 shares, worth US$231.0M. Across 6 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 450,000 shares valued at US$84.3M — a reduction of -1,925,000 shares quarter over quarter.. Notable position changes include a 53% trim in Q4 2025 (shares rose 22% over the following quarter), a 705% increase in Q1 2026 (shares rose 93% over the following quarter), a 81% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 725.00K $20.79M New
Q2 2025 1.20M $44.15M New
Q3 2025 630.00K $29.42M Reduce
Q4 2025 295.00K $23.50M Reduce
Q1 2026 2.38M $230.97M Add
Q2 2026 450.00K $84.28M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 61 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Vestal Point Capital, LP held RVMD?

Vestal Point Capital, LP has disclosed RVMD holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

What is Vestal Point Capital, LP's current position in RVMD?

As of Q2 2026, Vestal Point Capital, LP holds 450.00K shares of RVMD (REVOLUTION MEDICINES INC), valued at $84.28M, representing 1.97% of its reported portfolio and ranking #18.

Has Vestal Point Capital, LP been buying or selling RVMD?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP reduced its position in RVMD. The position peaked in Q1 2026 at 2.38M shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.